Thought Leadership
 
Email Page
Facilitating Competition and Innovation Isn't Easy: FDA's Latest Hearing On Biologics
September 14, 2018
Daniel Orr
FDLI

Axinn associate Brett Garrison edited the FDLI article, "Facilitating Competition and Innovation Isn’t Easy: FDA’s Latest Hearing On Biologics." Daniel Orr of Womble Bond Dickinson LLP authored the article.